全文获取类型
收费全文 | 3477篇 |
免费 | 261篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 213篇 |
妇产科学 | 63篇 |
基础医学 | 376篇 |
口腔科学 | 91篇 |
临床医学 | 333篇 |
内科学 | 819篇 |
皮肤病学 | 51篇 |
神经病学 | 134篇 |
特种医学 | 459篇 |
外科学 | 308篇 |
综合类 | 161篇 |
一般理论 | 1篇 |
预防医学 | 293篇 |
眼科学 | 53篇 |
药学 | 183篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 199篇 |
出版年
2022年 | 26篇 |
2021年 | 63篇 |
2020年 | 44篇 |
2019年 | 60篇 |
2018年 | 92篇 |
2017年 | 56篇 |
2016年 | 63篇 |
2015年 | 68篇 |
2014年 | 65篇 |
2013年 | 143篇 |
2012年 | 92篇 |
2011年 | 109篇 |
2010年 | 104篇 |
2009年 | 139篇 |
2008年 | 96篇 |
2007年 | 146篇 |
2006年 | 122篇 |
2005年 | 107篇 |
2004年 | 84篇 |
2003年 | 77篇 |
2002年 | 57篇 |
2001年 | 82篇 |
2000年 | 94篇 |
1999年 | 86篇 |
1998年 | 123篇 |
1997年 | 139篇 |
1996年 | 125篇 |
1995年 | 88篇 |
1994年 | 96篇 |
1993年 | 111篇 |
1992年 | 62篇 |
1991年 | 50篇 |
1990年 | 46篇 |
1989年 | 66篇 |
1988年 | 77篇 |
1987年 | 71篇 |
1986年 | 58篇 |
1985年 | 47篇 |
1984年 | 39篇 |
1983年 | 35篇 |
1982年 | 32篇 |
1981年 | 50篇 |
1980年 | 35篇 |
1979年 | 23篇 |
1978年 | 19篇 |
1977年 | 33篇 |
1976年 | 31篇 |
1973年 | 21篇 |
1969年 | 17篇 |
1967年 | 17篇 |
排序方式: 共有3766条查询结果,搜索用时 15 毫秒
71.
72.
BackgroundSmall bowel involvement of Clostridium difficile is increasingly encountered. Data on many management aspects are lacking.AimTo synthesis existing reports and assess the frequency, pathophysiology, outcomes, risk factors, diagnosis and management of C. difficle enteritis.MethodsA systematic review of the literature was conducted to evaluate evidence regarding frequency, pathophysiology, risk factors, optimal diagnosis, management and outcomes for C. difficle enteritis. Three major databases (PubMed, MEDLINE and the Cochrane Library) were searched. The review included original articles reporting C. difficle enteritis from January 1950 to December 2012.ResultsC. difficle enteritis is rare but increasingly encountered. Presentation is variable and distinct predisposing factors include emergency surgery, white race and increased age. Diagnosis generally involves a sensitive but often non specific screening test for C. difficile antigens. Oral metronidazole represents first line therapy and surgery may be required for complications. Outcomes are inconsistent but may be improving.ConclusionsA high index of clinical suspicion, early diagnosis and treatment are vital. Further prospective studies are needed to determine the significance of asymptomatic small bowel C. difficile infections. 相似文献
73.
74.
75.
76.
77.
78.
79.
Familial protein S deficiency with a variant protein S molecule in plasma and platelets 总被引:3,自引:0,他引:3
A protein S deficient family presenting a variant protein S molecule in plasma and platelets is described. The propositus, age 20, and two brothers suffered from venous thrombotic disease. The propositus, the only family member studied while taking oral anticoagulants, had a protein S antigen (ag) level of 17% and undetectable activity. As demonstrated by immunoblotting both the propositus and one clinically affected brother (42% ag, 7% activity) presented variant protein S molecules of 65,000 molecular weight (mol wt) while the other clinically affected brother (64% ag, 11% activity) had only protein S with normal electrophoretic mobility of 70,000 mol wt. The mother had normal protein S levels (93% ag, 100% activity) but had both normal and variant protein S molecules and based on her functional protein S data a normal anticoagulant activity of the variant molecule is suggested. One asymptomatic but protein S deficient sister (68% ag, 9% activity) as well as the asymptomatic protein S deficient father (59% ag, 10% activity) had only protein S molecules of 70,000 mol wt. The variant protein S bound to C4b-binding protein in plasma, and differed from normal protein S in carbohydrate content. Platelets of each family member contained the same immunoblotting pattern of normal and variant protein S forms as found in plasma, consistent with the hypothesis that protein S gene expression involves codominant expression of two alleles that is similar in cells that control the synthesis of both platelet and plasma forms of protein S. 相似文献
80.
Crosslinking the CD27 antigen on T cells provides a costimulatory signal that, in concert with T-cell receptor crosslinking, can induce T- cell proliferation and cellular immune activation. We find that chronic lymphocytic leukemia (CLL) B cells from most patients coexpress both membrane-bound and soluble CD27, along with its newly identified ligand, CD70. The expression of soluble CD27 may preclude leukemic B cells from stimulating T cells via CD70, thereby potentially impairing their ability to function as effective antigen-presenting cells. We find that leukemic B-cell expression of soluble and membrane-bound CD27 can be downmodulated through a CD40-dependent signal. This signal also induces enhanced expression of CD70 on both normal and leukemic B cells. We find that tumor necrosis factor (TNF)-alpha, or the Th1 cytokine interferon (IFN)-gamma, also can induce downmodulation of CD27, whereas Th2-associated cytokines interleukin-4 (IL-4) or IL-10 can enhance leukemic B-cell expression of this accessory molecule. The modulation of CD27 induced by these conditions is accompanied by reciprocal changes in the expression levels of CD70, suggesting that these accessory molecules may be engaged in reciprocal receptor-ligand downmodulation. Consistent with this, we observe that co-culture of CLL B cells with transfected murine plasmacytoma cells that express human CD70 affects downmodulation of CD27 and enhanced expression of CD70 on leukemic B cells, but does not affect expression of CD27 mRNA. However, we find that CD40-crosslinking, in addition to reducing the level of CD27 protein, also reduces leukemic B-cell expression of CD27 mRNA. This argues that the changes in the expression levels of CD27 following CD40-signaling are not simply due to induced increases in the expression levels of CD70. Finally, we demonstrate that reciprocal changes in expression of CD27 and CD70 may contribute to the enhanced antigen-presenting capacity of CLL B cells after CD40-dependent leukemic B-cell activation. These findings expand the understanding of the regulation of costimulatory molecules important in antigen presentation and also have implications for the immunobiology of and therapy for CLL. 相似文献